March 19, 2021
Vaccine hesitancy and variants challenge efforts to tame COVID-19
The Janssen Biotech, Inc/Johnson & Johnson COVID-19 vaccine received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) on February 27, joining the Pfizer-BioNTech and Moderna vaccines that received EUA in December 2020.
Free Daily News
- Smart t-shirt enables earlier discharge, safer recovery after urological cancer surgery
- Study compares robotic, laparoscopic cholecystectomy cost drivers
- Hospital closures rise in 2025 amid ongoing financial pressures
- AI-driven tech partnerships aim to enhance surgical planning, imaging
- Study: Stronger sense of mission reduces burnout, turnover risk among perioperative nurses
- AI agents sweep healthcare, promising speed and efficiency
- Novel liver transplant technique offers new hope for colorectal cancer patients
- Bipartisan bill would expand presidential trade authority over medical goods
- Legislation proposes granting CRNA practice authority to expand anesthesia access for veterans
- FDA announces Class 1 recall for implantable ports
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement